Pharmaceutical Composition for Stem Cell Division and Bacterial Virulence
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for stimulating stem cell differentiation and reducing bacterial virulence rely on genetic modification and genotoxic compounds, which are hazardous and inefficient, and existing compositions for tissue regeneration and antimicrobial therapy are limited in their effectiveness and specificity.
Innovation Solution
A pharmaceutical composition combining phosphodiesterase inhibitors, histone deacetylase inhibitors, and pharmaceutically acceptable excipients, along with unseparated mixtures of dipiridamol combinatorial derivatives formed by simultaneous modification with covalent modifiers, which activates tissue regeneration, stimulates stem cell division, and depresses bacterial virulence without genetic modification or genotoxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If genetic modification is used to stimulate stem cell differentiation, then stem cell yield is increased, but cancer formation hazard increases
Solution Approach 1:
The invention extracts and eliminates the harmful genetic modification step while retaining the beneficial stem cell differentiation effect. By using small-molecule compounds (phosphodiesterase inhibitors and histone deacetylase inhibitors) instead of genetic vectors, the patent removes the cancer formation hazard associated with genetic modification while maintaining stem cell yield enhancement.
Solution Approach 2:
The patent employs temporary, non-integrating small-molecule compounds rather than permanent genetic modifications. These compounds act transiently to stimulate stem cell differentiation and then are metabolized and eliminated, avoiding the persistent risks of genetic modification including cancer formation, while achieving the desired stem cell yield increase.
2Object-affected harmful factors
If genotoxic compounds are used to reduce bacterial virulence, then bacterial virulence is suppressed, but safety and efficacy are compromised
Solution Approach 1:
The invention converts the harmful effect of genotoxic compounds into a beneficial approach by using non-genotoxic mechanisms. Instead of damaging bacterial DNA to suppress virulence, the patent employs compounds that reversibly inhibit virulence factor expression through epigenetic and enzymatic pathways, achieving virulence suppression without compromising bacterial safety or treatment reliability.
Solution Approach 2:
The patent introduces small-molecule compounds as intermediaries that mediate between the host and bacteria. These compounds (phosphodiesterase inhibitors and histone deacetylase inhibitors) act as mediators to suppress bacterial virulence factors through host cellular mechanisms rather than directly attacking bacterial DNA, thereby maintaining safety and efficacy while reducing virulence.
3Productivity
If existing compositions are used for tissue regeneration, then some regeneration effect is achieved, but effectiveness and specificity are limited
Solution Approach 1:
The patent creates a composite pharmaceutical composition combining two distinct mechanisms: phosphodiesterase inhibitors (increasing cAMP levels) and histone deacetylase inhibitors (modifying chromatin structure). This composite approach synergistically enhances stem cell mobilization and tissue regeneration effectiveness while improving specificity compared to single-mechanism compositions.
Solution Approach 2:
The invention develops a multi-functional composition that simultaneously performs multiple functions: stimulating stem cell division, enhancing stem cell mobilization, suppressing bacterial virulence, and promoting tissue regeneration. This universal composition addresses multiple therapeutic needs with a single formulation, improving both effectiveness and specificity across different applications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition significantly enhances stem cell mobilization, accelerates tissue regeneration, and restores bacterial sensitivity to antibiotics, offering a safer and more effective approach for stem cell therapy and antimicrobial treatment.
Implementation Method 1
phosphodiesterase inhibitors, incl. dipirimadol... which when being used... have high bioactivity as a means of stem cell fission encouragement
Implementation Method 2
histone deacetylase inhibitors... able to scale up massively the yield percentage stem cells after genetic modification
Implementation Method 3
unseparated mixture of dipiridamol combinatorial derivatives obtained by means of simultaneous modification by at least two covalent modifying agents
Data Source
AI summary
Scope: The invention relates to organic and bioorganic combinatorial chemistry and pharmacia, namely to new combinatorial library of dipiridamol derivative and supramolecular structures based on them, which when being used not separated in individual components, have high bioactivity as a means of stem cell fission encouragement as pharmaceutical compositions combined with phosphodiesterase inhibitors and histone deacetylase inhibitors, as well as pharmaceutically acceptable excipients. The composition can also be used to struggle with resistant microorganisms by establishing their sensitivity to antibiotics.